Provided by Tiger Trade Technology Pte. Ltd.

Certara, Inc.

8.64
-0.3200-3.57%
Post-market: 8.51-0.1300-1.50%19:30 EDT
Volume:4.13M
Turnover:35.72M
Market Cap:1.32B
PE:-19.95
High:8.96
Open:8.90
Low:8.58
Close:8.96
52wk High:13.30
52wk Low:4.45
Shares:152.54M
Float Shares:109.98M
Volume Ratio:1.23
T/O Rate:3.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4331
EPS(LYR):-0.0100
ROE:-2.21%
ROA:0.77%
PB:1.36
PE(LYR):-864.09

Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 11

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 08

Altasciences, Certara form strategic partnership to speed early drug development

Reuters
·
May 07

BRIEF-Altasciences And Certara Announce Strategic Partnership To Accelerate Early Drug Development

Reuters
·
May 07

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development

THOMSON REUTERS
·
May 07

Barclays Remains a Hold on Certara (CERT)

TIPRANKS
·
Apr 23

Certara Strategic Business Divestiture Comes At Right Time, Says Analyst

Benzinga_recent_news
·
Apr 23

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AT&T, Yesway

Reuters
·
Apr 23

Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX) and Certara (CERT)

TIPRANKS
·
Apr 23

BUZZ-Certara rises after up to $135 million sale of regulatory documents business

Reuters
·
Apr 22

Certara agrees to sell regulatory, medical writing unit to Veristat for up to $135 million

Reuters
·
Apr 22

Certara Inc - Deal Expected to Close in Q2 2026

THOMSON REUTERS
·
Apr 22

Certara Inc - to Sell Regulatory and Medical Writing Business to Veristat for up to $135 Mln

THOMSON REUTERS
·
Apr 22

Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat

GlobeNewswire
·
Apr 22

Analysts Conflicted on These Healthcare Names: Vivos Therapeutics (VVOS), Certara (CERT) and Option Care Health (OPCH)

TIPRANKS
·
Apr 17

Certara Is Maintained at Overweight by Keybanc

Dow Jones
·
Apr 13

Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA) and Certara (CERT)

TIPRANKS
·
Apr 13